Open AccessPotential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinson’s Disease
Author(s) -
Lynda J. Peterson,
Kathleen P. Ismond,
Elisha Chapman,
Patrick C. Flood
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/z6g8-k054
Subject(s) - neuroprotection , parkinson's disease , adrenergic , neuroscience , pharmacology , medicine , disease , receptor , psychology